Bioethics for clinicians: 3. CapacityEdward Etchells, MD, MSc, FRCPC; Gilbert Sharpe, BA, LLB, LLM; Carl Elliott, MD, PhD; Peter A. Singer, MD, MPH, FRCPC
| Order now! |
Canadian Medical Association Journal 1996; 155: 657-661
[résumé] |
Series editor: Dr. Peter A. Singer, University of Toronto Joint Centre for Bioethics, 88 College St., Toronto ON M5G 1L4; fax 416 978-1911; peter.singer@utoronto.ca
© 1996 Canadian Medical Association (text and abstract/résumé)
Mr. H is a 65-year-old man admitted to hospital because of acute imbalance and clumsiness in the left arm. He is diagnosed with atrial fibrillation and infarction of the left cerebellar hemisphere. His clinician recommends warfarin therapy, but Mr. H. repeatedly refuses.
Mrs. I is a 79-year-old woman with noninsulin-dependent diabetes mellitus who is admitted to hospital with gangrene of the first and second toes of her right foot. She lives alone and does not like doctors. She receives intravenous antibiotic therapy for 1 week without response. Her clinicians recommend amputation of the affected toes, but she says "I don't know what you will do with them after you cut them off."
Mr. J is 74 years old and has severe Parkinson disease. He is admitted to hospital with psychosis caused by bromocriptine therapy. His clinician wishes to start treatment with clozapine, an antipsychotic drug with minimal extrapyramidal side effects but potentially severe hematologic side effects. When the clinician attempts to obtain consent Mr. J is unable to respond to any questions.
In Canadian common law there is no age below which a person is not presumed capable. A minor can give consent if he or she is able to understand the information about a treatment and to appreciate the risks and likely consequences of the treatment.[1] Some provinces have legislation that establishes the age of consent to treatment (Table 1); clinicians should familiarize themselves with the legislative requirements in their own province.
In some situations clinicians may be unsure about a patient's capacity. The patient may have a neurologic or psychiatric disease or may be behaving in a way that indicates lack of understanding. Although refusal of recommended treatment may cause a clinician to question a person's capacity,[8] refusal of treatment should not be considered evidence of incapacity.9 Most refusals are caused by factors other than incapacity.[10]
When a clinician is unsure about a patient's capacity an assessment is needed. The initial objective of assessment is to screen for incapacity. Patients who appear to be incapable after the screening assessment generally require further evaluation. Clinicians may use three different measures of capacity: cognitive function testing, general impressions of capacity and specific capacity assessments.
Cognitive function tests such as the Mini Mental State Examination[11] are reliable, easy to administer and familiar to clinicians in a wide variety of settings. However, although cognition and capacity are related, they are not identical.[1215] Most measures of cognitive status do not evaluate several cognitive functions, such as judgement and reasoning, that are relevant to capacity.[16] A person may have a perfect cognitive test score but still be incapable by virtue of delusions that directly affect the treatment decision. Another limitation of cognitive status tests is that cut-off scores for identifying incapacity have not been established.
Gaining a general impression of a patient's capacity is a simple and quick method of assessment but can be unreliable,[17] inaccurate[13,14] and easily biased.[18]
In a specific capacity assessment the clinician discloses information relevant to the treatment decision and then evaluates the person's ability to understand this information and to appreciate the consequences of his or her decision. The Aid to Capacity Evaluation is a decisional aid to assist clinicians in carrying out specific capacity assessments.[19] It prompts clinicians to probe seven relevant areas (Table 2), provides sample questions for the evaluation of each area and gives suggestions for scoring. Other decisional aids have been developed to assist with the assessment of the patient's capacity to complete an advance directive[20] and to consent to treatment,[2126] and to assist with the simultaneous assessment of several types of capacity.[27]
Specific capacity assessments have several strengths. First, they directly assess the patient's actual functioning while he or she is making a decision, which is exactly what the legal definition of capacity requires. Second, they are clinically feasible and quick: the median time for Aid to Capacity Evaluation assessments is 12 minutes.[19] Finally, specific capacity assessments are flexible and can easily be adapted to various clinical circumstances.
However, specific capacity assessments have certain drawbacks. First, they are only as good as the accompanying disclosure. If the clinician does not disclose information effectively, the capacity assessment will be inaccurate. Therefore, excellent communication skills are critical to accurate assessment. In practice, the process of disclosure should continue throughout the capacity assessment. For example, if a patient does not initially appreciate that he or she may be able to walk after a below-knee amputation, then this information should be redisclosed. Then the clinician can re-evaluate whether this consequence of below-knee amputation has been understood.
A second problem with specific capacity assessments relates to the evaluation of a patient's reasons for a decision. The goal is to ensure that the decision is not substantially based on a delusion and is not the result of depression. However, some "delusions" may represent personal, religious or cultural values that are not appreciated by the clinician. Similarly, it is difficult to determine whether a decision is substantially affected by the cognitive features of depression, such as hopelessness and feelings of worthlessness, guilt and persecution.[28,29]
A third problem is that a patient's capacity may fluctuate. If a person appears to be incapable the clinician should determine whether any reversible factors such as delirium or a drug reaction are at work. If such factors are identified the clinician should attempt to eliminate or minimize them and then repeat the assessment. There may also be factors that prevent a person from communicating effectively with the clinician, such as a language barrier or speech disturbance. Such factors must be addressed to ensure accurate capacity assessment.
Finally, clinicians may find it difficult to perform unbiased capacity assessments, particularly when the patient's choice goes against their recommendations. It is important to remember that agreement or disagreement with the patient's decision is not at issue; the purpose of capacity assessment is to evaluate the person's ability to understand relevant information and to appreciate the consequences of a decision.
If the result of screening indicates that a patient may be incapable, further expert assessment is generally recommended, particularly if the clinician is unsure about the assessment or if the person challenges the finding of incapacity. Expert assessments can be conducted by individual practitioners (e.g., psychiatrists and psychologists), hospital ethics committees or legal review boards. If a finding of incapacity is based primarily on the clinician's interpretation of the person's reason for his or her decision, then the clinician should seek further input from others, such as the patient's family or relevant representatives from the patient's cultural or religious group. If the clinician suspects that a decision is based substantially on delusions or depression, then psychiatric evaluation is recommended.
Mr. H's specific capacity assessment shows that he has the ability to understand his condition ("I have had a stroke to the left cerebellum, which has left me clumsy on the left side. It was caused by a blood clot from the heart"), the proposed treatment ("You want to thin my blood with warfarin"), the option of refusing ("I don't want it"), as well as the ability to appreciate the reasonably foreseeable consequences of refusing the treatment ("I might have another stroke without the pills, but I don't want them") and of accepting it ("You say that the pills might reduce the chance of stroke, but it can also cause bleeding"). Explaining the reason for his refusal, Mr. H says: "I think that the women who draw the blood are vampires. You want to thin my blood so it is easier for them to drink." Mr. H is subsequently evaluated by a psychiatrist, who diagnoses acute mania. Mr. H's wife later reveals that Mr. H had previously been diagnosed with manic depressive disorder but had stopped his lithium therapy several months before his stroke.
Mrs. I's specific capacity assessment showed that she had the ability to understand her condition ("My toes are dead. They are very smelly"), the proposed treatment ("You want to cut off my toes"), and the option of refusing ("I do not want you to cut them off"), as well as some ability to appreciate the reasonably foreseeable consequences of refusing ("You say I will die, but I don't know about this. I wonder what you will do with my toes after you cut them off. I don't really trust the doctors. I think they just want to give the students some practice"). Mrs. I reveals that she is a concentration-camp survivor with a deep mistrust of physicians. She also says that 7 years ago when she had gangrene of the left foot and refused amputation the foot had healed. Because the clinician remains unsure of Mrs. I's capacity and suspects depression, a psychiatric consultation is requested. Mrs. I admits to having a persistent depressed mood and several vegetative signs of depression. However, she denies feelings of hopelessness, guilt, persecution or worthlessness. Ultimately, Mrs. I is felt to be capable but depressed. She accepts treatment for depression. Her foot condition stabilizes and at 1 year of follow-up she is able to walk but still requires daily treatments for her foot.
Mr. J is re-evaluated 4 hours later, at which time he has gained maximum benefit from the medication for his Parkinson disease. At this time, he is able to communicate and answer questions, and is clearly capable.
We thank Ms. Sharon Smith for her careful preparation of the manuscript.